苏黄止咳胶囊联合多索茶碱对慢性持续期支气管哮喘的疗效及对肺功能、FeNO的影响

doi:10.3969/j.issn.1000-8535.2023.07.007

摘要/Abstract

摘要： 目的探讨苏黄止咳胶囊联合多索茶碱对慢性持续期支气管哮喘的疗效及对肺功能、呼出气一氧化氮（FeNO）的影响。方法选择2020年3月—2022年3月70例慢性持续期支气管哮喘患者,随机分为2组各35例,对照组仅予以多索茶碱治疗,研究组在对照组基础上加服苏黄止咳胶囊治疗。治疗3个月,采用哮喘控制测试（ACT）对患者进行评估,记录哮喘急性加重、急救药物使用情况及急诊入院情况,测定肺功能和呼出FeNO。结果 2组治疗1月的ACT评分比较无统计学意义（P>0.05）,治疗2、3个月时研究组的ACT评分高于对照组（P<0.05）。研究组哮喘急性加重次数、急救药物使用次数均少于对照组（P<0.05）,而2组急诊入院次数比较差异无统计学意义（P>0.05）。与基线值相比,2组治疗3个月时的肺功能指标无改变（P>0.05）且组间比较差异亦无统计学意义（P>0.05）;2组治疗3个月时的FeNO无改变（P>0.05）,而研究组的FeNO低于对照组（P<0.05）。结论苏黄止咳胶囊联合多索茶碱治疗慢性持续期支气管哮喘可降低FeNO,提高哮喘控制水平。

关键词: 支气管哮喘, 苏黄止咳胶囊, 多索茶碱, 肺功能, 呼出气一氧化氮

Abstract: Objective To investigate the effect of Suhuang Zhike capsule combined with doxofylline on chronic persistent bronchial asthma, pulmonary function and exhaled nitric oxide（FeNO）．Methods Seventy patients with chronic persistent bronchial asthma from March 2020 to March 2022 were randomly divided into two groups, 35 cases in each group．The control group was only treated with doxofylline, and the study group was treated with Suhuang Zhike capsule additionally．After 3 months of treatment, the patients were evaluated by asthma control test（ACT）, the acute exacerbation of asthma was recorded, and the pulmonary function and exhaled FeNO were measured．Results There was no statistical significance in the ACT score of the two groups after one month of treatment（P>0.05）．The ACT scores of the study group after two months and three months of treatment were significantly higher than those of the control group（P<0.05）．The times of acute exacerbation of asthma and the use of emergency drugs in the study group were less than those in the control group（P<0.05）, but there was no significant difference in the number of emergency hospitalizations between the two groups（P>0.05）．Compared with the baseline value, there was no significant change in lung function indexes in the two groups after 3 months of treatment（P>0.05）．Compared with the baseline value, there was no significant change in FeNO in the two groups after 3 months of treatment（P<0.05）, while FeNO in the study group was lower than that in the control group（P<0.05）．Conclusions Suhuang Zhike capsule combined with doxofylline in the treatment of chronic persistent bronchial asthma can reduce FeNO and improve the level of asthma control．

Key words: bronchial asthma, Suhuang Zhike capsule, doxofylline, pulmonary function, exhaled nitric oxide

张梅芳, 孙岚英, 赵学娟. 苏黄止咳胶囊联合多索茶碱对慢性持续期支气管哮喘的疗效及对肺功能、FeNO的影响[J]. 广州医药, 2023, 54(7): 40-44.

ZHANG Meifang, SUN Lanying, ZHAO Xuejuan. Effect of Suhuang Zhike capsule combined with doxofylline on chronic persistent bronchial asthma,pulmonary function and FeNO[J]. Guangzhou Medical Journal, 2023, 54(7): 40-44.

参考文献

[1] 中华医学会呼吸病学分会哮喘学组.中国支气管哮喘防治指南(2020年版)[J].中华结核和呼吸杂志2020,43(12):1023-1048.
[2] SHAHIN M,EL-LAWAH A A,AMIN A,et al.Study of serum vitamin D level in adult patients with bronchial asthma[J].Egyp J Chest Dis Tuber,2017,66(1):5-9.
[3] 林江涛,王文巧,周新,等.我国30个省市城区门诊支气管哮喘患者控制水平的调查结果[J].中华结核和呼吸杂志,2017,40(7):494-498.
[4] 候凯迪. 对比分析多索茶碱治疗支气管哮喘的临床疗效[J].重庆医学,2017,46(3):20-22.
[5] 张建丽. 硫酸特布他林雾化液和布地奈德混悬液联合多索茶碱治疗变异性哮喘患儿的临床研究[J].中国临床药理学杂志,2017,33(22):2215-2218.
[6] 周洋,张家洪.苏黄止咳胶囊联合沙美特罗/丙酸氟替卡松对咳嗽变异性哮喘患者气道炎症的影响[J].实用医学杂志,2016,32(2):298-299.
[7] 张涵,张家洪,马经平.苏黄止咳胶囊对支气管哮喘患者气道炎症及细胞免疫影响研究[J].中华肺部疾病杂志(电子版),2017,10(3):344-346.
[8] 谢小兵,高云,凌敏,等.苏黄止咳胶囊治疗541例咳嗽患者临床疗效观察[J].中国实用医药,2019,14(28):60-62.
[9] 金华良,周燕,王利民,等.从调控T淋巴细胞亚群失衡探讨健脾益气法改善支气管哮喘缓解期气道炎症的免疫学机制[J].中医杂志,2021,62(10):856-861.
[10] 郑炜东,曲妮妮.应用中医药干预辅助T淋巴细胞Th9治疗支气管哮喘前景展望[J].世界中西医结合杂志,2021,16(5):977-980.
[11] 郭超,童希洋,秦伟伟,等.苏黄止咳胶囊改善哮喘豚鼠气道重塑的作用及其机制[J].中成药,2021,43(4):893-901.
[12] KARRASCH S,LINDE K,G RÜCKER,et al.Accuracy of FENO for diagnosing asthma:A systematic review[J].Thorax,2017,72(2):109-116.
[13] 张忠德,高明,李际强,等.苏黄止咳胶囊对咳嗽变异性哮喘豚鼠模型疗效的实验研究[J].广州中医药大学学报,2016,33(5):693-697.
[14] SATO S,SAITO J,FUKUHARA A,et al.The clinical role of fractional exhaled nitric oxide in asthma control[J].Ann Allergy Asthma Immunol,2017,119(6):541-547.
[15] MATSUNAGA K,HIRANO T,OKA A,et al.Persistently high exhaled nitric oxide and loss of lung function in controlled asthma[J].Allergol Int,2016,65(3):266-271.